You will shortly be receiving an automatic email confirming your online registration and within the next 24 hours, you will receive your invoice and/or payment confirmation.
We look forward to welcoming you to the conference.
Submit Your Poster
Final chance to submit a poster abstract before the deadline.
All submissions are subject to approval by event organisers.
Submit your abstract for approval
See Poster Manual for requirements
Submission Deadline: Monday, September 18.
Your ticket also gives you access to the gala of the 10th World ADC Awards taking place during the conference, on October 18.
This is an exclusive event with limited capacity remaining.
Invitations will be considered on a first come first served basis, so register interest now to avoid disappointment!.
If you have any questions about your registration, please contact:
Telephone: +44 (0)20 3141 8700 or +1 617 455 4188
*Please note: Slight changes can occur to the agenda up until the start of the meeting. Please refer to the website and onsite materials for the most up-to-date version of the program.
Explore Related Related ADC & Engineered Antibodies Products
ADC & Engineered Antibodies
Maximizing the Therapeutic Window of ADCs & Engineered Antibodies
Conferences
The World ADC Series covers the full breadth and depth of drug conjugates from next-generation conjugates and ADC target selection to ADC analytical development and manufacturing. Our mission is to provide the industry with knowledge and connections to maximize the therapeutic window of drug conjugates.
Data
A manually curated database solution including clinical trials and drug records for preclinical, active, approved and discontinued drugs and treatments developed in partnership with the world's leading ADC drug developers and academics.
Networking
A vital year-round experience-sharing and problem-solving network to help drug developers make better ADC discovery decisions.
Research
A trusted provider of market intelligence for anyone looking to understand the complexities of ADC and Engineered Antibodies research and development.
